EudraCT Number: 2020-001048-24 Sponsor Protocol Number: NN7769-4514 Start Date: 2021-01-08
Sponsor Name: Novo Nordisk A/S
Full Title: A multinational, open-label, randomised, controlled trial to investigate efficacy and safety of NNC0365-3769 (Mim8) in adults and adolescents with haemophilia A with or without inhibitors.
Medical condition: Haemophilia A Haemophilia A with inhibitors
Disease: Version SOC Term Classification Code Term Level
20.0 100000004850 10018938 Haemophilia A (Factor VIII) LLT
20.0 100000004850 10053751 Hemophilia A with anti factor VIII LLT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2017-000358-20 Sponsor Protocol Number: G1T28-05 Start Date: 2017-07-12
Sponsor Name: G1 Therapeutics
Full Title: Phase 2 Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung Cancer
Medical condition: Untreated Extensive-Stage Small Cell Lung Cancer
Disease: Version SOC Term Classification Code Term Level
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10041068 Small cell lung cancer extensive stage PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: EE (Completed) LV (Completed) BG (Completed) ES (Completed) FR (Completed)
Trial results: (No results available)